Skip to main content
. Author manuscript; available in PMC: 2014 Aug 14.
Published in final edited form as: Cancer. 2012 May 8;118(22):5614–5622. doi: 10.1002/cncr.27593

Figure 1.

Figure 1

Patient Flow from the National Surgical Adjuvant Breast and Bowel Project C-07 trial to the Patient-Reported Outcomes (PRO) substudy and Long-Term Survivors study (LTS-01) to the overlapping subset available for long-term neurotoxicity analysis. FULV, fluorouracil and leucovorin; FLOX, FULV plus oxaliplatin.